Chemotherapy for gastric cancer in Japan

被引：10
作者：
Nishiyama, Masahiko [1 ]
机构：
[1] Saitama Med Univ, Int Med Ctr, Translat Res Ctr, Hidaka, Saitama 3501298, Japan
来源：
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 13卷 / 03期
关键词：
gastric cancer; chemotherapy; Japan; review;
D O I：
10.1007/s10147-008-0790-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：191 / 192
页数：2
相关论文
共 22 条
  • [11] Cancer pharmacogenomics: progress and obstacles toward the goal
    Masahiko Nishiyama
    [J]. International Journal of Clinical Oncology, 2005, 10 (1) : 3 - 4
  • [12] Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205)
    Ohtsu, A
    Shimada, Y
    Shirao, K
    Boku, N
    Hyodo, I
    Saito, H
    Yamamichi, N
    Miyata, Y
    Ikeda, N
    Yamamoto, S
    Fukuda, H
    Yoshida, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 54 - 59
  • [13] Current status and future prospects of chemotherapy for metastatic gastric cancer: A review
    Ohtsu A.
    [J]. Gastric Cancer, 2005, 8 (2) : 95 - 102
  • [14] Global cancer statistics, 2002
    Parkin, DM
    Bray, F
    Ferlay, J
    Pisani, P
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) : 74 - 108
  • [15] Chemotherapy of advanced gastric cancer
    Rivera, Fernando
    Vega-Villegas, M. Eugenia
    Lopez-Brea, Marta F.
    [J]. CANCER TREATMENT REVIEWS, 2007, 33 (04) : 315 - 324
  • [16] ROTH AD, 2004, ASCO 2004 ED BOOK, P199
  • [17] Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
    Sakuramoto, Shinichi
    Sasako, Mitsuru
    Yamaguchi, Toshiharu
    Kinoshita, Taira
    Fujii, Masashi
    Nashimoto, Atsushi
    Furukawa, Hiroshi
    Nakajima, Toshifusa
    Ohashi, Yasuo
    Imamura, Hiroshi
    Higashino, Masayuki
    Yamamura, Yoshitaka
    Kurita, Akira
    Arai, Kuniyoshi
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18) : 1810 - 1820
  • [18] SASAKO M, 1994, LANCET, V343, P1309
  • [19] Phase II study of a combination of irinotecan and S-1 in patients with advanced gastric cancer (OGSG0002)
    Uedo, Noriya
    Narahara, Hiroyuki
    Ishihara, Ryu
    Takiuchi, Hiroya
    Goto, Masahiro
    Fujitani, Kazumasa
    Hirao, Motohiro
    Tsujinaka, Toshimasa
    Imano, Motohiro
    Furukawa, Hiroshi
    Tsukuma, Hideaki
    Taguchi, Tetsuo
    [J]. ONCOLOGY, 2007, 73 (1-2) : 65 - 71
  • [20] Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
    Van Cutsem, Eric
    Moiseyenko, Vladimir M.
    Tjulandin, Sergei
    Majlis, Alejandro
    Constenla, Manuel
    Boni, Corrado
    Rodrigues, Adriano
    Fodor, Miguel
    Chao, Yee
    Voznyi, Edouard
    Risse, Marie-Laure
    Ajani, Jaffer A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (31) : 4991 - 4997
123